comparemela.com

Latest Breaking News On - Professor of computer sciences - Page 2 : comparemela.com

I am in a position to ask the right questions

I am in a position to ask the right questions
grocotts.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from grocotts.co.za Daily Mail and Mail on Sunday newspapers.

Ocugen Establishes Vaccine Scientific Advisory Board

Ocugen Establishes Vaccine Scientific Advisory Board
mychesco.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mychesco.com Daily Mail and Mail on Sunday newspapers.

Ocugen Establishes Vaccine Scientific Advisory Board – IT Business Net

Ocugen Establishes Vaccine Scientific Advisory Board – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Ocugen Establishes Vaccine Scientific Advisory BoardLeading experts to evaluate the clinical and regulatory path to approval in the US market of COVAXIN™, a whole-virion inactivated COVID-19 vaccine

Published: Dec 23, 2020 MALVERN, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) Ocugen, Inc., (NASDAQ: OCGN), a leading biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies, today announced the appointment of a vaccine scientific advisory board comprised of leading academic and industry experts in the vaccine field to evaluate the clinical and regulatory path to approval in the US market of Bharat Biotech’s COVAXIN™, a whole-virion inactivated COVID-19 vaccine candidate to be co-developed by Ocugen and Bharat Biotech for the US market. Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen remarked, “We are thrilled to welcome this group of esteemed thought leaders to the Ocugen team to assist in our co-development with Bharat Biotech of COVAXIN™. This unique yet traditional vaccine candidate is different from other options currently available in the US market with potentially broader coverage against multip

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.